bromhexine has been researched along with Respiratory Distress Syndrome in 5 studies
Bromhexine: A mucolytic agent used in the treatment of respiratory disorders associated with viscid or excessive mucus. (From Martindale, The Extra Pharmacopoeia, 30th ed, p744)
bromhexine : A substituted aniline that is 2,4-dibromoaniline which is substituted at position 6 by a [cyclohexyl(methyl)amino]methyl group. It is used (as the monohydrochloride salt) as a mucolytic for the treatment of respiratory disorders associated with productive cough (i.e. a cough characterised by the production of sputum).
Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The authors study the changes in cardiopulmonary function after application of bromhexine metabolite VIII (NA 872) in an animal model of adult respiratory distress syndrome (ARDS) and bromhexine glucose solution (BGS) in ARDS patients." | 7.66 | Application of bromhexine metabolite VIII (NA 872) and bromhexine-glucose in treatment of adult respiratory distress syndrome; experimental and clinical results . ( Dauberschmidt, R; Frenzke, H; Hieronymi, U; Kuckelt, W; Lachmann, B; Meyer, M; Mrochen, H; Scharfenberg, J; Winsel, K, 1980) |
| "Ambroxol, a drug capable of elevating the phospholipid content in healthy rabbit lungs, was tested on two models of experimental lung injury, lung changes in sepsis induced by a peritonitis and in bromcarbamide intoxication." | 3.67 | Ambroxol increases the choline but not fatty acid incorporation into lung phospholipids in experimental lung disorders. ( Müller, B; von Wichert, P; Wilke, A, 1987) |
| "The authors study the changes in cardiopulmonary function after application of bromhexine metabolite VIII (NA 872) in an animal model of adult respiratory distress syndrome (ARDS) and bromhexine glucose solution (BGS) in ARDS patients." | 3.66 | Application of bromhexine metabolite VIII (NA 872) and bromhexine-glucose in treatment of adult respiratory distress syndrome; experimental and clinical results . ( Dauberschmidt, R; Frenzke, H; Hieronymi, U; Kuckelt, W; Lachmann, B; Meyer, M; Mrochen, H; Scharfenberg, J; Winsel, K, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lipworth, B | 1 |
| Chan, R | 1 |
| Lipworth, S | 1 |
| RuiWen Kuo, C | 1 |
| Dauberschmidt, R | 2 |
| Kuckelt, W | 2 |
| Bender, V | 1 |
| Hieronymi, U | 2 |
| Mrochen, H | 2 |
| Winsel, K | 2 |
| Zinsmeyer, J | 1 |
| Meyer, M | 2 |
| Scharfenberg, J | 1 |
| Lachmann, B | 1 |
| Frenzke, H | 1 |
| Disse, BG | 1 |
| Wilke, A | 1 |
| Müller, B | 1 |
| von Wichert, P | 1 |
1 review available for bromhexine and Respiratory Distress Syndrome
| Article | Year |
|---|---|
The pharmacology of ambroxol--review and new results.
Topics: Airway Resistance; Ambroxol; Animals; Bromhexine; Bronchitis; Chronic Disease; Humans; Infant, Newbo | 1987 |
4 other studies available for bromhexine and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Weathering the Cytokine Storm in Susceptible Patients with Severe SARS-CoV-2 Infection.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Age Factors; Angiotensin-Converting Enzyme Inhi | 2020 |
Effects of bromhexine metabolite VIII (NA 872) in an animal model of the respiratory distress syndrome.
Topics: Ambroxol; Animals; Blood Circulation; Bromhexine; Carbon Dioxide; Disease Models, Animal; Lactates; | 1980 |
Application of bromhexine metabolite VIII (NA 872) and bromhexine-glucose in treatment of adult respiratory distress syndrome; experimental and clinical results .
Topics: Animals; Bromhexine; Humans; Lung; Lung Compliance; Respiration; Respiratory Dead Space; Respiratory | 1980 |
Ambroxol increases the choline but not fatty acid incorporation into lung phospholipids in experimental lung disorders.
Topics: Ambroxol; Animals; Bromhexine; Choline; Fatty Acids; Female; Lung; Lung Diseases; Male; Peritonitis; | 1987 |